(Bloomberg) Shares of small biotech firm ABVC BioPharma Inc. rose as much as 930% in premarket trading on Monday before shedding gains to below 300% on retail frenzy.
ABVC attracted attention on trading social network, StockTwits, helping it to gain at least $25 dollars apiece.
Attention on ABVC grew as the company filed for a mixed securities shelf on Friday for an estimated value of $50 million. The company also filed for patent applications of some drugs for treating attention-deficit hyperactivity disorder and depression.
ABVC: NASDAQ is up +291.34%.
